HTLV-1 INFECTION
Clinical trials for HTLV-1 INFECTION explained in plain language.
Never miss a new study
Get alerted when new HTLV-1 INFECTION trials appear
Sign up with your email to follow new studies for HTLV-1 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo targets rare leukemia
Disease control TerminatedThis early-stage trial tests adding lenalidomide to standard chemotherapy (EPOCH) for adult T-cell leukemia-lymphoma, a rare and aggressive blood cancer linked to HTLV-1 infection. The main goal is to find the safest dose of lenalidomide when used with chemo. Up to 30 adults with…
Matched conditions: HTLV-1 INFECTION
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
HTLV-1 study tracks survival to unlock secrets of rare Virus-Linked cancer
Knowledge-focused OngoingThis study follows 69 people infected with HTLV-1, some of whom have developed a rare blood cancer called adult T-cell leukemia/lymphoma. Researchers will track survival rates over 2 and 5 years, along with viral levels and genetic markers. The goal is to better understand how th…
Matched conditions: HTLV-1 INFECTION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC